Keyphrases
Sublingual Buprenorphine
47%
Opioids
47%
Buprenorphine
47%
Transdermal Buprenorphine
42%
Release Treatment
42%
Maternal Opioid Use
42%
Full Agonist
42%
Postpartum Period
42%
Observational Cohort Study
42%
Hospital Transition
42%
Medications for Opioid Use Disorder
42%
Extended Release
42%
Single Center
10%
Opioid Use Disorder
10%
Clinical Course
9%
Hospitalized Patients
9%
Milligram Morphine Equivalents
9%
Urine Toxicology
5%
Postpartum Patient
5%
High-risk Population
5%
Maintenance Dose
5%
Euphoria
5%
Toxicological Testing
5%
Total Dose
5%
Intoxication
5%
Retrospective Case Series
5%
Pharmacology, Toxicology and Pharmaceutical Science
Opiate
100%
Disease
87%
Buprenorphine
84%
Opiate Agonist
42%
Transdermal
42%
Cohort Study
42%
Disease Course
5%
Morphine
5%